Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either ? and ? linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Bio-Therapeutic Glycoproteins market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Bio-Therapeutic Glycoproteins market. Detailed analysis of key players, along with key growth strategies adopted by Bio-Therapeutic Glycoproteins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis Pharmaceuticals Corp
Merck
Biogen
Genzyme Corp
GlaxoSmithKline
Genentech
Abbott Laboratories
Hoffmann-La Roche
Amgen
By Type:
Antisera
Cytokines
Clotting Factors
Hormones
Enzymes
Enzyme Inhibitors
By End-User:
Oncology and Haematology
Diabetes
Cardiology
Inflammatory Diseases
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bio-Therapeutic Glycoproteins Market
-
1.3 Market Segment by Type
-
1.3.1 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Antisera from 2016 to 2027
-
1.3.2 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Cytokines from 2016 to 2027
-
1.3.3 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Clotting Factors from 2016 to 2027
-
1.3.4 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Hormones from 2016 to 2027
-
1.3.5 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Enzymes from 2016 to 2027
-
1.3.6 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Enzyme Inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Oncology and Haematology from 2016 to 2027
-
1.4.2 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Diabetes from 2016 to 2027
-
1.4.3 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Cardiology from 2016 to 2027
-
1.4.4 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Inflammatory Diseases from 2016 to 2027
-
1.4.5 USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Bio-Therapeutic Glycoproteins Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bio-Therapeutic Glycoproteins by Major Types
-
3.4.1 Market Size and Growth Rate of Antisera
-
3.4.2 Market Size and Growth Rate of Cytokines
-
3.4.3 Market Size and Growth Rate of Clotting Factors
-
3.4.4 Market Size and Growth Rate of Hormones
-
3.4.5 Market Size and Growth Rate of Enzymes
-
3.4.6 Market Size and Growth Rate of Enzyme Inhibitors
4 Segmentation of Bio-Therapeutic Glycoproteins Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bio-Therapeutic Glycoproteins by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bio-Therapeutic Glycoproteins in Oncology and Haematology
-
4.4.2 Market Size and Growth Rate of Bio-Therapeutic Glycoproteins in Diabetes
-
4.4.3 Market Size and Growth Rate of Bio-Therapeutic Glycoproteins in Cardiology
-
4.4.4 Market Size and Growth Rate of Bio-Therapeutic Glycoproteins in Inflammatory Diseases
-
4.4.5 Market Size and Growth Rate of Bio-Therapeutic Glycoproteins in Others
5 Market Analysis by Regions
-
5.1 USA Bio-Therapeutic Glycoproteins Production Analysis by Regions
-
5.2 USA Bio-Therapeutic Glycoproteins Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Bio-Therapeutic Glycoproteins Landscape Analysis
-
6.1 West USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major Types
-
6.2 West USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major End-Users
7 South USA Bio-Therapeutic Glycoproteins Landscape Analysis
-
7.1 South USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major Types
-
7.2 South USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major End-Users
8 Middle West USA Bio-Therapeutic Glycoproteins Landscape Analysis
-
8.1 Middle West USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major Types
-
8.2 Middle West USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major End-Users
9 Northeast USA Bio-Therapeutic Glycoproteins Landscape Analysis
-
9.1 Northeast USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major Types
-
9.2 Northeast USA Bio-Therapeutic Glycoproteins Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novartis Pharmaceuticals Corp
-
10.1.1 Novartis Pharmaceuticals Corp Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Merck
-
10.2.1 Merck Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Biogen
-
10.3.1 Biogen Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Genzyme Corp
-
10.4.1 Genzyme Corp Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 GlaxoSmithKline
-
10.5.1 GlaxoSmithKline Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Genentech
-
10.6.1 Genentech Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Abbott Laboratories
-
10.7.1 Abbott Laboratories Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Hoffmann-La Roche
-
10.8.1 Hoffmann-La Roche Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Amgen
-
10.9.1 Amgen Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Antisera from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Cytokines from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Clotting Factors from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Hormones from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Enzymes from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Enzyme Inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Oncology and Haematology from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Diabetes from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Cardiology from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Inflammatory Diseases from 2016 to 2027
-
Figure USA Bio-Therapeutic Glycoproteins Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Bio-Therapeutic Glycoproteins Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Bio-Therapeutic Glycoproteins
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bio-Therapeutic Glycoproteins by Different Types from 2016 to 2027
-
Table Consumption Share of Bio-Therapeutic Glycoproteins by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antisera
-
Figure Market Size and Growth Rate of Cytokines
-
Figure Market Size and Growth Rate of Clotting Factors
-
Figure Market Size and Growth Rate of Hormones
-
Figure Market Size and Growth Rate of Enzymes
-
Figure Market Size and Growth Rate of Enzyme Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Bio-Therapeutic Glycoproteins by Different End-Users from 2016 to 2027
-
Table Consumption Share of Bio-Therapeutic Glycoproteins by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology and Haematology
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Cardiology
-
Figure Market Size and Growth Rate of Inflammatory Diseases
-
Figure Market Size and Growth Rate of Others
-
Table USA Bio-Therapeutic Glycoproteins Production by Regions
-
Table USA Bio-Therapeutic Glycoproteins Production Share by Regions
-
Figure USA Bio-Therapeutic Glycoproteins Production Share by Regions in 2016
-
Figure USA Bio-Therapeutic Glycoproteins Production Share by Regions in 2021
-
Figure USA Bio-Therapeutic Glycoproteins Production Share by Regions in 2027
-
Table USA Bio-Therapeutic Glycoproteins Consumption by Regions
-
Table USA Bio-Therapeutic Glycoproteins Consumption Share by Regions
-
Figure USA Bio-Therapeutic Glycoproteins Consumption Share by Regions in 2016
-
Figure USA Bio-Therapeutic Glycoproteins Consumption Share by Regions in 2021
-
Figure USA Bio-Therapeutic Glycoproteins Consumption Share by Regions in 2027
-
Table West USA Bio-Therapeutic Glycoproteins Consumption by Types from 2016 to 2027
-
Table West USA Bio-Therapeutic Glycoproteins Consumption Share by Types from 2016 to 2027
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2016
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2021
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2027
-
Table West USA Bio-Therapeutic Glycoproteins Consumption by End-Users from 2016 to 2027
-
Table West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2016
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2021
-
Figure West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2027
-
Table South USA Bio-Therapeutic Glycoproteins Consumption by Types from 2016 to 2027
-
Table South USA Bio-Therapeutic Glycoproteins Consumption Share by Types from 2016 to 2027
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2016
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2021
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2027
-
Table South USA Bio-Therapeutic Glycoproteins Consumption by End-Users from 2016 to 2027
-
Table South USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2016
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2021
-
Figure South USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2027
-
Table Middle West USA Bio-Therapeutic Glycoproteins Consumption by Types from 2016 to 2027
-
Table Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2016
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2021
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2027
-
Table Middle West USA Bio-Therapeutic Glycoproteins Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2016
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2021
-
Figure Middle West USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2027
-
Table Northeast USA Bio-Therapeutic Glycoproteins Consumption by Types from 2016 to 2027
-
Table Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2016
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2021
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by Types in 2027
-
Table Northeast USA Bio-Therapeutic Glycoproteins Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2016
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2021
-
Figure Northeast USA Bio-Therapeutic Glycoproteins Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis Pharmaceuticals Corp
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharmaceuticals Corp
-
Figure Sales and Growth Rate Analysis of Novartis Pharmaceuticals Corp
-
Figure Revenue and Market Share Analysis of Novartis Pharmaceuticals Corp
-
Table Product and Service Introduction of Novartis Pharmaceuticals Corp
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Biogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
-
Figure Sales and Growth Rate Analysis of Biogen
-
Figure Revenue and Market Share Analysis of Biogen
-
Table Product and Service Introduction of Biogen
-
Table Company Profile and Development Status of Genzyme Corp
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme Corp
-
Figure Sales and Growth Rate Analysis of Genzyme Corp
-
Figure Revenue and Market Share Analysis of Genzyme Corp
-
Table Product and Service Introduction of Genzyme Corp
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Hoffmann-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche
-
Figure Sales and Growth Rate Analysis of Hoffmann-La Roche
-
Figure Revenue and Market Share Analysis of Hoffmann-La Roche
-
Table Product and Service Introduction of Hoffmann-La Roche
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
